These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 34346294)

  • 21. Immune Infiltration of MMP14 in Pan Cancer and Its Prognostic Effect on Tumors.
    Li M; Li S; Zhou L; Yang L; Wu X; Tang B; Xie S; Fang L; Zheng S; Hong T
    Front Oncol; 2021; 11():717606. PubMed ID: 34604053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SHCBP1 Is a Prognostic Biomarker Related to the Tumour Immune Microenvironment in Pan-Cancer.
    Huang Y; You M; Wu Q; Zhu W; Guo F; Lin W
    Ann Clin Lab Sci; 2022 Nov; 52(6):904-917. PubMed ID: 36564070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic pan-cancer analysis insights into ICAM1 as an immunological and prognostic biomarker.
    Yang C; Ni B; Shen L; Li Z; Zhou L; Wu H; Zhang Y; Liu L; Liu J; Tian L; Yan L; Jin X
    FASEB J; 2024 Jul; 38(13):e23802. PubMed ID: 38979944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer.
    Chen P; Xu J; Cui Z; Wu S; Xie T; Zhang X
    Front Immunol; 2023; 14():1071675. PubMed ID: 36761737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pan-cancer analysis of the prognostic and immunological role of GJB2: a potential target for survival and immunotherapy.
    Jia Y; Guo B; Zhang W; Wang F; Zhang Y; Zhang Q; Li E
    Front Oncol; 2023; 13():1110207. PubMed ID: 37427102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic and immune regulating roles of YIF1B in Pan-Cancer: a potential target for both survival and therapy response evaluation.
    Liu J; Chen Z; Zhao P; Li W
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32648580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and Prognosis.
    Chen R; Wu W; Chen SY; Liu ZZ; Wen ZP; Yu J; Zhang LB; Liu Z; Zhang J; Luo P; Zeng WJ; Cheng Q
    Front Immunol; 2022; 13():831542. PubMed ID: 35979347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive Pan-Cancer Analysis of GINS2 for Human Tumour Prognosis and as an Immunological Biomarker.
    Meng W; Jiang Z; Zhang X; Cai B; Ma L; Guan Y
    Comput Math Methods Med; 2022; 2022():3119721. PubMed ID: 36466552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive Multiomics Analysis Identified IQGAP3 as a Potential Prognostic Marker in Pan-Cancer.
    Wang G; Zhou X; Li Y; Zhao M; Zou Y; Lu Q; Wu Y
    Dis Markers; 2022; 2022():4822964. PubMed ID: 36164370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comprehensive pan-cancer analysis on the immunological role and prognostic value of
    Yang Y; Jiang L; Wang S; Chen H; Yi M; Wu Y; Li Z; Fang X
    Transl Cancer Res; 2022 Sep; 11(9):3187-3208. PubMed ID: 36237259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic pan-cancer analysis identifies cuproptosis-related gene DLAT as an immunological and prognostic biomarker.
    Xu L; Wu P; Rong A; Li K; Xiao X; Zhang Y; Wu H
    Aging (Albany NY); 2023 May; 15(10):4269-4287. PubMed ID: 37199628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis.
    Liu P; Wang X; Pan L; Han B; He Z
    Front Immunol; 2022; 13():901784. PubMed ID: 35720327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pan-Cancer Study of SHC-Adaptor Protein 1 (SHC1) as a Diagnostic, Prognostic and Immunological Biomarker in Human Cancer.
    Chen J; Gao G; Li L; Ding J; Chen X; Lei J; Long H; Wu L; Long X; He L; Shen Y; Yang J; Lu Y; Sun Y
    Front Genet; 2022; 13():817118. PubMed ID: 35601500
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker.
    Zhang W; Wu C; Zhou K; Cao Y; Zhou W; Zhang X; Deng D
    Front Genet; 2022; 13():993438. PubMed ID: 36685895
    [No Abstract]   [Full Text] [Related]  

  • 35. Expression of RAP1B is associated with poor prognosis and promotes an aggressive phenotype in gastric cancer.
    Yang Y; Li M; Yan Y; Zhang J; Sun K; Qu JK; Wang JS; Duan XY
    Oncol Rep; 2015 Nov; 34(5):2385-94. PubMed ID: 26329876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pan-Cancer Analysis of the N6-Methyladenosine Eraser FTO as a Potential Prognostic and Immunological Biomarker.
    Zhao C; Liu Y; Ju S; Wang X
    Int J Gen Med; 2021; 14():7411-7422. PubMed ID: 34744452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive Analysis of RELL2 as a Potential Biomarker Associated with Tumor Immune Infiltrating Cells in a Pan-Cancer Analysis.
    Musha K; Ge X; Ablikim N; Lu B; Chen C; Huang J
    Dis Markers; 2022; 2022():5009512. PubMed ID: 35634441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis.
    Wang G; Li Y; Pan R; Yin X; Jia C; She Y; Huang L; Yang G; Chi H; Tian G
    Aging (Albany NY); 2024 Jan; 16(1):872-910. PubMed ID: 38217545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EMP1 correlated with cancer progression and immune characteristics in pan-cancer and ovarian cancer.
    Zhang J; Yang J; Li X; Mao L; Zhang Y; Liu Y; Bao Y
    Mol Genet Genomics; 2024 May; 299(1):51. PubMed ID: 38743077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pan-Cancer Analysis of the Prognostic and Immunological Role of SMG5: A Biomarker for Cancers.
    Yang L; Wei J; Ma X; Cheng R; Zhang H; Jin T
    Oncology; 2024; 102(2):168-182. PubMed ID: 37699361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.